Spero Therapeutics Participates in Guggenheim Healthcare Innovation Conference

• Spero Therapeutics will attend the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on Nov. 10, 2026.
• CEO Esther Rajavelu will participate in a fireside chat at 10:30 a.m. ET, with leadership available for investor meetings.
• Management will also meet investors at the Jefferies Global Healthcare Conference in London on Nov. 18-19.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spero Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611021605PRIMZONEFULLFEED9868426) on November 02, 2026, and is solely responsible for the information contained therein.